Page 7 - Sohini Das

West Bengal election results: Industrialists pin hopes on BJP's win

Strained Centre-state relations had long made investors wary, a sentiment reinforced by Trinamool leader Mamata Banerjee's rise on the back of a land agitation in Singur and Nandigram

Sun Pharma exploring Eurobonds, bond swaps to fund US-based Organon buy

According to bankers, the Indian pharma major plans to raise around $10 billion from various sources, while the remaining will be funded through internal accruals

EV sales jump nearly 70% in Jan-Apr; momentum sustains beyond March spike

April volumes hold near peak despite fewer selling days; Tata leads while M&M and Maruti gain share amid broad-based growth

Drug exports to US fall 10% in FY26 as EU and Africa drive growth

India's pharma exports hit a record in FY26 but growth slowed as US demand weakened; vaccines, bulk drugs and diversification into EU and Africa supported gains

Sun Pharma bets on Organon front-end to drive global growth, efficiencies

Sun Pharma sees its Organon acquisition as a platform to expand globally, boost in-licensing, and improve long-term efficiencies through a stronger commercial front-end

Asia-Oceania emerging auto industry's centre of gravity: Shailesh Chandra

Asia-Oceania leads global vehicle growth and demand, consolidating its role as both manufacturing hub and consumption market, amid uneven recovery across Europe and the Americas

Sun Pharmaceutical acquires US-based Organon in $11.75 billion deal

Combined entity to have revenue of $12.4 billion; enters biosimilars big league

Proton therapy expansion to put India high on global cancer care map

Rising capacity, cost advantage, and new centres position India as a key destination for advanced cancer care, though access gaps and affordability remain challenges

India EV sales double, mid-market surges as entry segment shrinks

EV volumes rise 87 per cent in FY26, with ₹20-30 lakh segment gaining share while entry-level adoption weakens due to affordability and product gaps

Chinese API price surge tests India's pharma buffers amid West Asia crisis

Rising API prices from China and feedstock disruptions amid the West Asia crisis are tightening cost pressures on India's pharma sector despite temporary inventory buffers

Medical device makers push 'fair pricing' model amid MRP concerns

Medical device makers have urged a shift to a fair pricing model amid concerns over inflated MRPs, even as stakeholders remain divided on pricing practices in healthcare

Results preview: Pharma growth steady in Q4, but US drag weighs on margins

India's pharma and healthcare firms may post steady Q4 revenue growth, but weak US generics and rising costs are likely to keep margins under pressure

Maruti Suzuki retires Ignis; supply woes hit S-Presso and WagonR

Maruti Suzuki phases out Ignis amid weak demand, even as strong bookings and production constraints lead to supply shortages in Wagon R and S-Presso models

GLP-1 sees strong return dosage in China and Japan as India lags on value

Global drugmakers are prioritising China and Japan for GLP-1 investments due to stronger pricing power and adoption, while India remains a large but price-sensitive market with slower premium uptake

SML Mahindra Q4FY26 PAT rises 2.4% to ₹54 crore, top line surges 16%

Despite modest profit growth, SML Mahindra reports strong revenue gains and outlines plans to expand market share and enter electric bus segment

Q4 results preview: Automakers may report strong volume-led growth

Auto companies are likely to post strong volume-led growth in Q4FY26, but rising input costs and commodity inflation are beginning to weigh on margins across segments

Shipping bottlenecks squeeze pharma flows as Hormuz crisis impact deepens

India's pharmaceutical industry remains dependent on China for bulk drugs, particularly fermentation-based antibiotics, vitamins and intermediates

Scooters set to overtake motorcycles as EV shift reshapes India's 2W market

Replacement demand recovery is expected to support near-term growth, while rising electrification and changing consumer preferences may drive scooters to overtake motorcycles in the long run

Electric 2-wheeler maker Ather to cut aluminium content to ease costs

Ather plans to reduce aluminium content in scooters to cut costs and improve margins, with up to 15 per cent savings expected on its upcoming EL platform

From treatment to trend, slimming drug boom sparks misuse concerns

Doctors caution against cosmetic misuse of GLP-1 drugs as cheaper generics boost access, raising risks of unsupervised use and short-term weight-loss trends